Amruta Reddy Poreddy

This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Medibeacon Inc., Galera Labs, LLC, Galera Therapeutics, LLC. Active years: 2012-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amruta Reddy Poreddy. Retrieved from https://idiyas.com/inventor/amruta-reddy-poreddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 7)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 39(Granted Patents)

Company Filing History:

Galera Therapeutics, LLC

Medibeacon Development LLC

patents

Years Active: 2012-2015

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9150837 - Polyethylene glycolated superoxide dismutase mimetics (2015-10-06),

2. 9005581 - Modified pyrazine derivatives and uses thereof (2015-04-14),

3. 8946419 - (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives (2015-02-03),

4. 8703100 - Modified pyrazine derivatives and uses thereof (2014-04-22),

5. 8697033 - Modified pyrazine derivatives and uses thereof (2014-04-15),

6. 8481734 - Pyrazine derivatives and uses thereof, including in medical imaging and visualization applications (2013-07-09),

7. 8217166 - Polyethylene glycolated superoxide dismutase mimetics (2012-07-10),

Title: The Innovative Contributions of Amruta Reddy Poreddy

Introduction

Amruta Reddy Poreddy, based in St. Louis, MO, is an accomplished inventor with a remarkable portfolio that includes seven patents. His innovative research focuses on health-related compounds that can potentially lead to significant advancements in medical treatments.

Latest Patents

Among his latest patents, Poreddy has developed polyethylene glycolated superoxide dismutase mimetics. This invention encompasses compounds and methods for leveraging a superoxide dismutase mimetic covalently linked to polyethylene glycol. This innovative approach aims to provide new solutions for preventing or treating diseases associated with superoxide anions. His methods also include protocols for assessing the safety and efficacy of these compounds in lab animals and humans.

Another significant patent involves modified pyrazine derivatives with multiple poly(ethylene glycol) containing substituents. These compounds are designed for renal system visualization in patients, providing diagnostics through luminescence upon excitation by electromagnetic radiation. This pioneering work represents a significant leap in the field of medical imaging.

Career Highlights

Throughout his career, Amruta Reddy Poreddy has collaborated with notable companies such as MediBeacon Inc. and MediBeacon Development LLC. His work in these organizations has contributed substantially to the development of new medical technologies and methodologies.

Collaborations

Poreddy has worked alongside esteemed colleagues, including William L. Neumann and Daniela Salvemini. These collaborations reflect a synergy of expertise in the pursuit of groundbreaking innovations in healthcare.

Conclusion

Amruta Reddy Poreddy's inventive contributions have the potential to revolutionize treatments for various medical conditions. With his ongoing research and patented technologies, he continues to play a vital role in the advancement of therapeutic interventions, showcasing the impact of dedicated inventors in the scientific community.

Profile summary based on public USPTO records.